Sensius

Sensius

Private
RotterdamHealthcare & Life Scienceshttps://www.sensiusthermotherapy.com/

Last Round

Series A

Jun 11, 2025

Total Funding Raised

$27.39M

Company Overview

Sensius is a medical technology company developing a precision thermotherapy platform designed to enhance standard cancer treatments such as radiotherapy and chemotherapy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

thermotherapy systemadjuvant cancer therapyhyperthermia therapymicrowave thermotherapysolid tumor therapymedtechhead and neck cancerradiotherapy sensitizerdeep tumor heatingcancer therapy deviceoncology techtreatment planning softwareradiotherapy workflow integrationbreast cancer treatmentmelanoma treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sensius Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sensius Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 11, 2025
AcceleratorFeb 15, 2023
GrantJun 20, 2022
SeedJul 11, 2017

Key People

Founding team and executive leadership

Paul van den Biggelaar

Co-Founder And CEO

Founding Team

Stan van Oppen

CFO

Executive Team

Sensius Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 26, 2025

    Grew 27% QoQ, from 11 to 14 employees.

  • Jul 2, 2025

    Monthly visitors grew 303% MoM.

Sensius Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sensius Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sensius's valuation, stock price, and market status.

Firmographic Details

HeadquartersRotterdam
Employee Range12
Year Founded2015
Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.